U.S. scientists say a recent genetic study of developmental brain disorders might lead to a better understanding of a number of congenital diseases.
The University of California-Irvine study is the first to find mutations of the structural proteins in brain cells -- beta-actin -- are linked with such disorders as deafness and dystonia. The research also suggests genetic variants of the proteins may play a wider role with inherited human diseases.
The study's lead author, Vincent Procaccio, said the findings provide vital clues to the basis of some developmental disorders and make early diagnosis possible for diseases such as dystonia, allowing for greater treatment opportunities.
"These types of actin proteins are prevalent throughout the body and play a key role in processes that are an essential part of development," said Procaccio, an assistant professor of pediatrics. "To find that these mutations are involved with brain disorders seems to be the tip of an iceberg. Since beta-actin is involved with many developmental cell functions, it would appear that its genetic variants can be involved with a number of other congenital disorders."
Study results appeared in the June issue of the American Journal of Human Genetics.
Copyright 2006 by United Press International
Related stories:
Developing unique brain maps to assist surgery and research
Researchers from the Howard Florey Institute in Melbourne are developing new technology to create individualised brain maps that will revolutionise diagnosis of disease and enhance the accuracy of brain surgery.
Mechanism may explain aspects of brain impairment seen in Fragile X Syndrome
Scientists report that a protein associated with a common form of mental retardation plays an important role in intracellular trafficking within neurons. The research, published by Cell Press in the June issue of the journal
Developmental Cell, reveals new information about how neuronal communication and plasticity are affected in Fragile X Syndrome (FXS).
Gene therapy slows progression of Batten Disease
Gene therapy that helps defective brain cells get rid of "garbage" appears both safe and effective at slowing down Batten disease, according to promising findings from NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Researchers Pinpoint Gene Mutations Responsible for 10 Percent of Schizophrenia
Scans of the genome of patients with schizophrenia have revealed rare spontaneous copy number mutations that account for at least 10 percent of the non-familial cases of the disease. Researchers describe specific genetic mutations present in individuals who have schizophrenia, but not present in their biological parents who do not have the disease.
At the synapse: Gene may shed light on neurological disorders
In our brains, where millions of signals move across a network of neurons like runners in a relay race, all the critical baton passes take place at synapses. These small gaps between nerve cell endings have to be just the right size for messages to transmit properly. Synapses that grow too large or too small are associated with motor and cognitive impairment, learning and memory difficulties, and other neurological disorders.
Scientists discover a molecular scaffold that guides connections between brain cells
Nonsignaling glial cells can direct synapse formation in the forging of neural networks
Brain cells known as neurons process information by joining into complex networks, transmitting signals to each other across junctions called synapses. But “neurons don’t just connect to other neurons,” emphasizes Z. Josh Huang, Ph.D., “in a lot of cases, they connect to very specific partners, at particular spots.”
Autistic mannerisms reduced by sensory treatment
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they’re seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
New gene discovered for new form of intellectual disability
The Centre for Addiction and Mental Health (CAMH) has discovered a new form of intellectual disability involving mental retardation (MR) along with the eye defect retinitis pigmentosa (RP). CAMH also discovered the previously unidentified gene that causes this disorder, CC2D2A.